Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children

Scandinavian Journal of Infectious Diseases

Volumn 45, Issue 7, 2013, Pages 526-530

  Sillanpää, Heidi ^a   Skogman, Barbro H ^b   Sarvas, Heikki ^a   Seppälä, Ilkka J T ^a   Lahdenne, Pekka ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Center for Clinical Research Dalarna   (Sweden)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cerebrospinal fluid; Children; CXCL13; Lyme neuroborreliosis

Indexed keywords

CXCL13 CHEMOKINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CHILD; CONTROLLED STUDY; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLAGELLUM; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; PLEOCYTOSIS; PRESCHOOL CHILD; PROTEIN CEREBROSPINAL FLUID LEVEL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; CHEMOKINE CXCL13; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; IMMUNOASSAY; LYME NEUROBORRELIOSIS; MALE;

EID: 84879120602     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2013.776700     Document Type: Article

References (21)

1. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17: 8-16, e1-4.
2. Brouqui P, B acellar F, B aranton G, B irtles RJ, B joersdorff A, Blanco JR, et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin MicrobioLinfect 2004; 10: 1108-32.
3. Aguero-Rosenfeld ME, Wang G, Schwartz I, W ormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005; 18: 484-509.
4. Broekhuijsen-van Henten D M, Braun K P, Wolfs TF. C linical presentation of childhood neuroborreliosis; neurological examination may be normal. Arch Dis Child 2010; 95: 910-4.
5. Skogman B H, Croner S, Nordwall M, Eknefelt M, Ernerudh J, Forsberg P. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome . Pediatr Infect Dis J 2008; 27: 1089-94.
6. Eppes SC. D iagnosis, treatment, and prevention of Lyme disease in children. Paediatr Drugs 2003; 5: 363-72.
7. Oschmann P, Wellensiek HJ, Zhong W, D orndorf W, Pfl ughaupt KW. Relationship between the Borrelia burgdorferi specifi c immune response and different stages and syndromes in neuroborreliosis. Infection 1997; 25: 292-7.
8. Tveitnes D, O ymar K, N atas O. L aboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms. Scand J Infect Dis 2009; 41: 355-62.
9. Skogman B H, Croner S, F orsberg P, E rnerudh J, L ahdenne P, Sillanpaa H, et al. Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fl uid. Pediatr Infect Dis J 2008; 27: 605-12.
10. Rupprecht T A, P fi ster H W, A ngele B, K astenbauer S, W ilske B, Koedel U. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 2005; 65: 448-50.
11. T umani H, P fi ster H W, L udolph AC, Brettschneider J. The chemokine CXCL13 in acute neuroborreliosis . J Neurol Neurosurg Psychiatry 2010; 81: 929-33. Erratum in: J Neurol Neurosurg Psychiatry 2010;81:1177.
12. Kowarik MC, Cepok S, Sellner, J, Grummel V, Weber M S, Korn T, et al. CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinfl ammation. J Neuroinfl ammation 2012; 9: 93.
13. Zajkowska J, M oniuszko-Malinowska A, P ancewicz S A, Muszy ń ska-Mazur A, Kondrusik M, Grygorczuk S, et al. Evaluation of CXCL10, CXCL11, CXCL12, and CXCL13 chemokines in serum and cerebrospinal fl uid in patients with tick borne encephalitis (TBE). Adv Med Sci 2011; 56: 311-7.
14. Tjernberg I, H enningsson A J, E liasson I, F orsberg P, E rnerudh J. Diagnostic performance of cerebrospinal fl uid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. J Infect 2010; 62: 149-58.
15. Wutte N, B erghold A, L offl er S, Z enz W, D aghofer E, Krainberger I, et al. CXCL13 chemokine in pediatric and adult neuroborreliosis. Acta Neurol Scand 2011; 124: 321-8.
16. van Burgel ND, B akels F, K roes AC, van Dam AP. D iscriminating Lyme neuroborreliosis from other neuro-infl ammatory diseases using levels of CXCL13 in cerebrospinal fl uid. J Clin Microbiol 2011; 49: 2027-30.
17. Schmidt C, P late A, A ngele B, P fi ster HW, W ick M, K oedel U, et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011; 76: 1051-8.
18. Rupprecht T A, K irschning CJ, P opp B, K astenbauer S, Fingerle V, Pfi ster HW, et al. Borrelia garinii induces CXCL13 production in human monocytes through toll-like receptor 2. Infect Immun 2007; 75: 4351-6.
19. Rot A, v on Andrian UH. C hemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22: 891-928.
20. Wilske B, Fingerle V, S chulte-Spechtel U. M icrobiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 2007; 49: 13-21.
21. S tanek G, Fingerle V, H unfeld K P, J aulhac B, K aiser R, Krause A, et al. Lyme borreliosis: clinical case defi nitions for diagnosis and management in Europe. Clin MicrobioLinfect 2011; 17: 69-79.